Injection perfusion médicaments
Titre original de l'avis
Norway – Medical equipments, pharmaceuticals and personal care products – 2801c Medicines infusion injection
Score d'opportunité
Pourquoi ce score ?
Opportunité
54 / 100
Complexité
60 / 100
Facteurs de risque
The available data does not include the detailed procurement documents, product specifications, pricing templates, fram...
No estimated value or framework maximum value is disclosed, making pricing strategy, capacity planning, and expected op...
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Informations clés
- Pouvoir adjudicateur
- SYKEHUSINNKJØP HF
- Pays
- Norvège
- CPV
- 33000000 - Medical equipments, pharmaceuticals and personal care products +1 autres
- Date limite
- Sep 17, 2026
Aperçu
Moderate opportunityFaits clés
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Jan 2030
- Supply of various medicines for use in infusion injections.
- Performance location: Norway.
Afficher le résumé complet
Open procedure for a framework agreement covering various medicines for infusion injections in Norway. The structured data identifies one lot, mandatory electronic submission, Norwegian language, and a submission deadline of 17 September 2026 at 10:00. Procurement documents appear available through the Ivalua portal, but the underlying procurement documents were not provided or analyzed. Contract value, selection criteria, and award criteria are missing. The structured data also conflicts with the XML notice on EU funding status.
Risques
The available data does not include the detailed procurement documents, product specifications, pricing templates, fram...
No estimated value or framework maximum value is disclosed, making pricing strategy, capacity planning, and expected op...
L'analyse peut être incomplète
Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.
Exigences clés
Technical
- Open procedure.
- Supply contract for medicinal products.
Administrative
- Electronic submission is required through the specified Ivalua portal.
Critères d'attribution
Lot 1
Acheteur
Localisation
VADSØ, NOR
Profil acheteur
Identifiant
916879067
Activité
Health
Lots (1)
LOT-0001
Medicines for Infusion and Injection
Supply of various medicines intended for use in infusion injections in Norway. The lot is identified as a framework agreement with a planned period from 1 February 2028 to 31 January 2030. Detailed product requirements and commercial conditions are not available in the provided data.
Localisation
Durée
Catégorie
Critères d'attribution
Date limite
Détails des critères
Sykehusinnkjøp HF, division Pharmaceuticals, shall procure various medicines for use in infusion injections. The contracting authorities for this competition are the four regional health authorities in Norway, Helse Sør-Øst RHF, Helse Vest RHF, Helse Midt-Norway RHF and Helse Nord RHF.
Codes CPV supplémentaires
Note sur la valeur
Afficher les données TED originales
Titre original du lot
2801c Medicines infusion injection
Description TED originale
Sykehusinnkjøp HF, division Pharmaceuticals, shall procure various medicines for use in infusion injections. The contracting authorities for this competition are the four regional health authorities in Norway, Helse Sør-Øst RHF, Helse Vest RHF, Helse Midt-Norway RHF and Helse Nord RHF.
Détails de la procédure
- Date de publication
- 23 Jun 2026
- Langues
- English, Norwegian
Métadonnées de référence
- Base juridique
- 32014L0024
Identifiants de référence
- ID de l'appel d'offres
- 431517-2026
Documents (1)
Appels d'offres similaires
Romania – Various medicinal products – ACORD CADRU FURNIZARE MEDICAMENTE
Poland – Medical consumables – Dostawa sterylnych i niesterylnych wyrobów medycznych dla pacjentów Szpitala Specjalistycznego w Zabrzu Sp. z o.o.; Nr sprawy DZP/14 PN/2026.
Poland – Pharmaceutical products – Dostawa produktów leczniczych - część nr 2
Belgium – Various medicinal products – Biosimilars: Infliximab IV, Tocilizumab IV en SC, Denosumab SC en Epoëtine alfa
Romania – Various medicinal products – MEDICAMENTE LOT 259
Poland – Various medicinal products – Dostawy produktów leczniczych
Score d'opportunité
Pourquoi ce score ?
Opportunité
54 / 100
Complexité
60 / 100
Facteurs de risque
The available data does not include the detailed procurement documents, product specifications, pricing templates, fram...
No estimated value or framework maximum value is disclosed, making pricing strategy, capacity planning, and expected op...
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications